New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The fetal bovine serum market was valued at USD 2.9 billion in 2023 with significant growth and is projected to reach USD 12.9 billion by 2033 with an outstanding CAGR of 16.5%.
The global fetal bovine serum market is experiencing significant expansion, driven by the escalating demand for treating acute and chronic lung diseases and continuous advancements in research and development. Also known as FBS or fetal calf serum, it serves as a vital supplement in cell culture applications across various industries, including biotechnology, biology, and medical research. FBS, rich in proteins and growth factors, supports cell proliferation, particularly in eukaryotic cells.
Get additional highlights on major revenue-generating segments, Request a Fetal Bovine Serum Market sample report at https://marketresearch.biz/report/global-fetal-bovine-serum-market/request-sample/
This versatile serum caters to diverse industries such as research, academics, and diagnostics, enhancing experimental outcomes with its nutrient-rich composition. It offers a robust culture system for various cell types, characterized by low levels of antibodies and growth factors, simplifying its utility. With over 1,000 components, including lipids, hormones, and enzymes, FBS provides essential elements for cell growth.
The use of FBS extends to vaccine production, cancer research, and biotechnology, contributing to stability, proliferation, and nutrient support in cell cultures. The market is poised for expansion as the demand for FBS increases, driven by its proven efficacy in eukaryotic cell culture processing and its role as an exceptional source of nutrients in animal and basal cell culture. Ready-to-use culture media further contribute to the anticipated growth of the FBS market in the coming years.
Key Takeaways
- Vaccine production rules the application market segment due to its research and production to fight infectious diseases.
- Biotech and pharmaceutical dominates the end-use market segment due to increasing investments by pharmaceutical corporations in R&D, rising biopharmaceutical demand, and biotech industry growth.
- North America dominates the fetal bovine serum market, claiming a 35.00% share, fueled by a robust pharmaceutical and biotechnology industry.
Driving Factors
Surge in Biopharmaceutical Growth
The market growth of fetal bovine serum is expanding quickly across many nations due to their expanding biopharmaceutical sectors and investments made in healthcare infrastructure, as well as an increase in R&D within life sciences and rising biopharmaceutical demands, factors that are fueling market expansion for this biopharmaceutical industry. Cell culture is integral to producing therapeutic proteins, vaccines, and other biopharmaceuticals such as vaccines.
Rise in Diseases Occurrence
FBS is becoming a vital asset in medical research for drug development as well as toxicology testing, providing essential clues for diagnosing and treating ailments. With chronic and infectious diseases on the rise, there is an ever-increasing need for research and development efforts that make FBS essential. This key trend is expected to persist and increase accordingly, necessitating more use of FBS for research into medical conditions as well as disease studies.
To understand how our report can bring a difference to your business strategy, Inquire about a brochure at https://marketresearch.biz/report/global-fetal-bovine-serum-market/#inquiry
Restraining Factors
Scientific and Ethical Concerns Limitation
FBS production is limited due to it being an end product from the meat industry; availability depends on changes in that sector of the industry. As FBS grows in pharmaceuticals, biomedical research, and other life science applications, its supply is struggling to keep up with market demands. This imbalance between demand and supply leads to higher prices as well as possible shortages, making it hard for manufacturers and researchers to rely on FBS as a reliable resource, further impeding market trend expansion and stability.
Growth Opportunities
Rising Application in Drug Discovery and Vaccine Production
FBS has played an increasing role in producing vaccines, particularly given the recent surge in vaccine research. FBS market growth can be attributed to its growing use in vaccine and drug discovery processes, in vitro tests using FBS, and screening compounds that could potentially be utilized for pharmaceutical research. FBS plays an essential role in this area; combined with an increased focus on creating new medications and vaccines for development purposes, this represents a tremendous growth opportunity as demand for reliable serum rises steadily across the pharmaceutical and biotech industries.
Have Queries? Speak to an expert or To Download/Request a Sample, Click here.
| Report Attribute | Details |
| Market Value (2023) | US$ 2.9 Billion |
| Market Size (2033) | US$ 12.9 Billion |
| CAGR (from 2024 to 2033) | 16.5% from 2024 to 2033 |
| North America Region Revenue Share | 35.00% |
| Historic Period | 2016 to 2023 |
| Base Year | 2023 |
| Forecast Year | 2024 to 2033 |
Regional Analysis
North America dominates the fetal bovine serum market, claiming a 35.00% share, fueled by a robust pharmaceutical and biotechnology industry. The region's wealth of biomedical research facilities and stringent quality control standards ensure reliability and safety in FBS utilization. Europe follows suit, driven by regulatory standards and ethical sourcing practices. In Asia-Pacific, rapid market growth is propelled by an expanding biotech sector, increased R&D activities, and rising demand for cell culture media, presenting opportunities for FBS market expansion in the region's emerging biotechnology landscape.
Segment Analysis
By application type, vaccine production rules the market segment due to its research and production. With global efforts underway to combat infectious diseases such as the COVID-19 pandemic spreading worldwide, its growth is becoming ever more drastic. In cell-based research, FBS is utilized for cultivating cells under in vitro conditions. FBS is used in the diagnostics and drug discovery industries to develop and test new diagnostic and therapeutic approaches, assess toxicity testing of chemical and pharmaceutical substances, facilitate in vitro fertilization processes as well as cell therapy treatments, promote cell growth and development, and aid cell therapy treatments.
By end-user type, biotech and pharmaceutical dominates the market segment due to increasing investments by pharmaceutical corporations in R&D, rising biopharmaceutical demand, and biotech industry growth. FBS plays an essential role in cell culture for research and production activities as a result. Its growth can be explained by this fact alone. Academic institutions often utilize FBS for research and education; diagnostic labs use FBS in various tests; and IVF centers also frequently incorporate it when conducting reproductive techniques and procedures with FBS as a key component.
For more insights on the historical and Forecast market data from 2016 to 2033 - download a sample report at https://marketresearch.biz/report/global-fetal-bovine-serum-market/request-sample/
Segments covered in this report
By Application
- Vaccine production
- Cell-based research
- Diagnostics
- Drug discovery
- Toxicity testing
- In-vitro fertilization
- Cell therapy
By End-User
- Pharmaceuticals and Biotechnology Industries
- Academic Institutes
- Research labs
- Diagnostic labs
- IVF centres
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Grow your profit margin with Marketresearch.biz - Purchase This Premium Report at https://marketresearch.biz/purchase-report/?report_id=42637
Competitive Landscape Analysis
In the global fetal bovine serum (FBS) market, major industry influencers include leading suppliers Danaher (Cytiva) and Merck KGaA (Sigma Aldrich), known for their high-quality serum products crucial for cell culture applications. Specialized providers like HiMedia Laboratories Pvt. Ltd. and Bio-Techne support diverse research needs, while Sera Scandia (Biowest) and Sartorius (Biological Industries) offer tailored serum solutions. Niche providers Atlas Biologicals and Rocky Mountain Biologicals provide reliable sources in the market, alongside industry giants PAN-Biotech and Thermo Fisher Scientific Inc., contributing to the biomedical research and bioprocessing landscape.
Key Players
- Danaher (Cytiva)
- Merck KGaA (Sigma Aldrich)
- HiMedia Laboratories Pvt. Ltd
- Bio-Techne
- Sera Scandia (Biowest)
- Sartorius (Biological Industries)
- Atlas Biologicals
- Rocky Mountain Biologicals
- PAN-Biotech
- Thermo Fisher Scientific Inc.
- Bovogen Biologicals Pty Ltd
Recent Developments
- In 2023, Clever Carnivore, a biotech startup, secured $7 million in seed round funding to expand its low-cost cultivated pork sausage production. This funding indicates growing interest and investment in the cultivated meat sector, which often relies on FBS for cell culture.
- In August 2023, Omeat launched "Plenty," a potent and cost-effective replacement for fetal bovine serum (FBS). This development aimed to improve price points for cultivated meat production.
- In September 2022, scientists from the National University of Singapore (NUS) developed a novel technique to grow cell-based meat using magnetic fields. This innovative method reduces reliance on animal products, making it a greener, cleaner, safer, and more cost-effective way to produce cultured meat.
Browse More Related Reports
- Cosmeceuticals Market is projected to reach USD 112.0 Bn by 2032, with a CAGR of 7.1% from 2023 to 2032, compared to USD 57.4 Bn in 2022.
- Vegan Collagen Market is anticipated to be valued at USD 4735.5 Mn by 2032, registering a CAGR of 24.4% during the forecast period, up from USD 563.5 Mn in 2022.
- Skin Lightening Products Market is forecasted to grow to USD 16.27 Bn by 2032, at a CAGR of 5.8% from 2023 to 2032, surpassing the 2022 value of USD 9.26 Bn.
- Cosmetic Raw Materials Market is expected to achieve USD 48.2 Mn by 2032, exhibiting a CAGR of 5.1% from 2023 to 2032, compared to USD 28.23 Mn in 2022.
- Herbal Beauty Products Market is poised to reach USD 192.31 Bn by 2032, growing at a CAGR of 5.2% from 2023 to 2032, starting from USD 115.84 Bn in 2022.
About Us:
MarketResearch.Biz (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. MarketResearch.Biz provides customization to suit any specific or unique requirement and tailor-made reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.
Follow Us on LinkedIn: https://www.linkedin.com/company/marketresearch-biz/
Follow Us on Facebook: https://www.facebook.com/marketresearch.biz
Follow Us on Twitter: https://twitter.com/PrudourResearch
